v3.25.2
SEGMENT INFORMATION (Tables)
6 Months Ended
Jun. 30, 2025
SEGMENT INFORMATION  
Schedule of Segment Information
b.Segment information:

Six Months Ended June 30, 

Three Months Ended June 30, 

(U.S. dollars in thousands)

2025

2024

2025

2024

Revenues from customers

$

25,771

$

17,222

$

15,658

$

13,474

Less:

Employee salaries and related expenses

10,649

10,357

5,444

5,213

Sub-contractors expense

7,463

4,764

4,773

2,609

Interest expense

761

379

Interest income

(528)

(757)

(272)

(374)

Depreciation

706

641

360

319

Other segment expenses*

10,552

8,461

4,692

7,600

Income (loss) before taxes on income

(3,071)

(7,005)

661

(2,272)

Taxes on income (tax benefit)

384

(207)

497

(69)

Segment net income (loss)

$

(3,455)

$

(6,798)

$

164

$

(2,203)

* Other expenses included in net income includes raw materials, rent and utilities and others.

Schedule of Disaggregation of Revenues
c.The following table summarizes the Company’s disaggregation of revenues:

Six Months Ended June 30, 

Three Months Ended June 30, 

(U.S. dollars in thousands)

2025

2024

    

2025

2024

Gaucher disease:

 

Pfizer (Ireland)

$

12,626

$

8,001

$

5,647

$

6,874

Fiocruz (Brazil)

$

3,016

$

7,266

$

-

$

4,716

Fabry disease:

Chiesi (Italy)

$

9,793

$

1,714

$

9,793

$

1,714

Total revenues from selling goods

$

25,435

$

16,981

$

15,440

$

13,304

Revenues from license and R&D services

$

336

$

241

$

218

$

170